MML Investors Services’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
JSAM
AT
AWC
RBC
WWM
PCIA
FF
AWMT
MML Investors Services's PPH Position: Q2 2026 in Review
MML Investors Services opened a new position in VanEck Pharmaceutical ETF (PPH) in Q2 2026: 2,158 shares worth $236K. The stake represents ﹤0.01% of the portfolio and ranks #2984 among its holdings. This is a return to the name: MML Investors Services previously reported a position in PPH as recently as Q4 2025.
MML Investors Services first reported a position in PPH in Q3 2022 and has held it in 12 quarters since. The position peaked at $441K in Q2 2024. 80 funds tracked by Wall St. Rank hold PPH as of Q2 2026.
- MML Investors Services held 2,158 shares of VanEck Pharmaceutical ETF worth $236K as of Q2 2026.
- VanEck Pharmaceutical ETF was a new MML Investors Services position in Q2 2026.
- VanEck Pharmaceutical ETF made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2984 holding.
- MML Investors Services first reported a position in VanEck Pharmaceutical ETF in Q3 2022 and has held it in 12 quarters since.
- MML Investors Services's VanEck Pharmaceutical ETF position peaked at $441K in Q2 2024.
- 80 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.
Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.